Liver cirrhosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
1999
2002
2003
Schaffner, 1963, Capillarization of the sinusoids, Gastroenterology, 44, 339, 10.1016/S0016-5085(63)80130-4
Desmet, 2004, Cirrhosis reversal: a duel between dogma and myth, J Hepatol, 40, 860, 10.1016/j.jhep.2004.03.007
Wanless, 2000, Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis, Arch Pathol Lab Med, 124, 1599, 10.5858/2000-124-1599-ROHC
1994
2005
Pirovino, 1988, Cutaneous spider nevi in liver cirrhosis: capillary microscopical and hormonal investigations, Klin Wochenschr, 66, 298, 10.1007/BF01727516
Foutch, 1988, Cutaneous vascular spiders in cirrhotic patients: correlation with hemorrhage from esophageal varices, Am J Gastroenterol, 83, 723
Cattau, 1982, The accuracy of the physical exam in the diagnosis of suspected ascites, JAMA, 247, 1164, 10.1001/jama.1982.03320330060027
Erlinger, 1991, Cirrhosis: clinical aspects, 380
Muercke, 1956, The finger-nails in hypoalbumenemia: a new physical sign, BMJ, 4979, 1327, 10.1136/bmj.1.4979.1327
Epstein, 1979, Hypertrophic hepatic osteoarthropathy. Clinical roentgenologic, biochemical hormonal and cardiorespiratory studies, and review of the literature, Am J Med, 67, 88, 10.1016/0002-9343(79)90078-0
Attali, 1987, Dupuytren's contracture, alcohol consumption, and chronic liver disease, Arch Intern Med, 147, 1065, 10.1001/archinte.1987.00370060061012
Van Thiel, 1985, Liver disease and the hypothalamic pituitary gonadal axis, Semin Liver Dis, 5, 35, 10.1055/s-2008-1041756
Tangerman, 1994, Cause and composition of foetor hepaticus, Lancet, 343, 483, 10.1016/S0140-6736(94)92729-4
Poynard, 1997, Natural history of liver fibrosis progression in patients with chronic hepatitis C, Lancet, 349, 825, 10.1016/S0140-6736(96)07642-8
Bellentani, 1999, Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study, Gut, 44, 874, 10.1136/gut.44.6.874
Bellentani, 1997, Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group, Gut, 41, 845, 10.1136/gut.41.6.845
Clark, 2006, The epidemiology of nonalcoholic fatty liver disease in adults, J Clin Gastroenterol, 40, S5
Farrell, 2006, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, 43, S99, 10.1002/hep.20973
Conn, 1993, Cirrhosis, 875
Groszmann, 2005, Portal hypertension. From bedside to bench, J Clin Gastroenterol, 39, S125, 10.1097/01.mcg.0000155552.14396.3d
Pratt, 1999, Evaluation of the liver A: laboratory tests, 205
Papadakis, 1990, Hyponatraemia in patients with cirrhosis, Q J Med, 76, 675
Peck-Radosavljevic, 2000, Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production, Blood, 95, 795, 10.1182/blood.V95.3.795.003k25_795_801
Martinez-Noguera, 2002, Doppler in hepatic cirrhosis and chronic hepatitis, Semin Ultrasound CT MR, 23, 19, 10.1016/S0887-2171(02)90027-2
Di Lelio, 1989, Cirrhosis: diagnosis with sonographic study of the liver surface, Radiology, 172, 389, 10.1148/radiology.172.2.2526349
Tchelepi, 2002, Sonography of diffuse liver disease, J Ultrasound Med, 21, 1023, 10.7863/jum.2002.21.9.1023
Awaya, 2002, Cirrhosis: modified caudate-right lobe ratio, Radiology, 224, 769, 10.1148/radiol.2243011495
Albrecht, 1999, Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent, Lancet, 353, 1579, 10.1016/S0140-6736(98)06373-9
Blomley, 2003, Liver microbubble transit time compared with histology and Child-Pugh score in diffuse liver disease: a cross sectional study, Gut, 52, 1188, 10.1136/gut.52.8.1188
Kim, 2001, Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients, J Ultrasound Med, 20, 99, 10.7863/jum.2001.20.2.99
Lencioni, 2002, Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound, Eur Radiol, 12, 151, 10.1007/s003300101022
Ito, 1999, Viral-induced cirrhosis: Grading of severity using MR imaging, AJR Am J Roentgenol, 173, 591, 10.2214/ajr.173.3.10470885
Choi, 2001, Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography, J Comput Assist Tomogr, 25, 777, 10.1097/00004728-200109000-00018
Burrel, 2003, MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation, Hepatology, 38, 1034, 10.1002/hep.1840380430
Bonkovsky, 1999, Hepatic iron concentration: Noninvasive estimation by means of MR imaging techniques, Radiology, 212, 227, 10.1148/radiology.212.1.r99jl35227
Qayyum, 2005, Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques—initial experience, Radiology, 237, 507, 10.1148/radiol.2372040539
Ziol, 2005, Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C, Hepatology, 41, 48, 10.1002/hep.20506
Abdi, 1979, Sampling variability on percutaneous liver biopsy, Arch Intern Med, 139, 667, 10.1001/archinte.1979.03630430043014
Bedossa, 2003, Sampling variability of liver fibrosis in chronic hepatitis C, Hepatology, 38, 1449, 10.1016/j.hep.2003.09.022
Regev, 2002, Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection, Am J Gastroenterol, 97, 2614, 10.1111/j.1572-0241.2002.06038.x
Ratziu, 2005, Sampling variability of liver biopsy in nonalcoholic fatty liver disease, Gastroenterology, 128, 1898, 10.1053/j.gastro.2005.03.084
Pugh, 1973, Transection of the oesophagus for bleeding esophageal varicies, Br J Surg, 60, 646, 10.1002/bjs.1800600817
Infante-Rivard, 1987, Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics, Hepatology, 7, 660, 10.1002/hep.1840070408
de Franchis, 1992, Why do varices bleed?, Gastroenterol Clin North Am, 21, 85, 10.1016/S0889-8553(21)00179-5
Wiesner, 2003, Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, 124, 91, 10.1053/gast.2003.50016
Wiesner, 2005, Evidence-based evolution of the MELD/PELD liver allocation policy, Liver Transpl, 11, 261, 10.1002/lt.20362
Huo, 2005, Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score, J Hepatol, 42, 826, 10.1016/j.jhep.2005.01.019
Powell, 1968, Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease, Am J Med, 44, 406, 10.1016/0002-9343(68)90111-3
Orrego, 1987, Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis, Gastroenterology, 92, 208, 10.1016/0016-5085(87)90861-4
Runyon, 1997, Historical aspects of treatment of patients with cirrhosis and ascites, Semin Liver Dis, 17, 163, 10.1055/s-2007-1007195
Stickel, 2002, Cocarcinogenic effects of alcohol in hepatocarcinogenesis, Gut, 51, 132, 10.1136/gut.51.1.132
Everson, 2005, Management of cirrhosis due to chronic hepatitis C, J Hepatol, 42, S65, 10.1016/j.jhep.2005.01.009
Poynard, 2002, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, 122, 1303, 10.1053/gast.2002.33023
Dienstag, 2003, Histological outcome during long-term lamivudine therapy, Gastroenterology, 124, 105, 10.1053/gast.2003.50013
Liaw, 2004, Lamivudine for patients with chronic hepatitis B and advanced liver disease, N Engl J Med, 351, 1521, 10.1056/NEJMoa033364
Villeneuve, 2000, Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B, Hepatology, 31, 207, 10.1002/hep.510310130
Fontana, 2002, Determinants of early mortality in patients with decompensated chronic hepatitis B treated with antiviral therapy, Gastroenterology, 123, 719, 10.1053/gast.2002.35352
Hadziyannis, 2005, Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B, N Engl J Med, 352, 2673, 10.1056/NEJMoa042957
Chang, 2005, A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients, Gastroenterology, 129, 1198, 10.1053/j.gastro.2005.06.055
Lai, 2005, A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B, Gastroenterology, 129, 528, 10.1016/j.gastro.2005.05.053
Schiff, 2003, Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients, Hepatology, 38, 1419
Roberts, 1996, Prognosis of histological cirrhosis in type 1 autoimmune hepatitis, Gastroenterology, 110, 848, 10.1053/gast.1996.v110.pm8608895
Dufour, 1997, Reversibility of hepatic fibrosis in autoimmune hepatitis, Ann Intern Med, 127, 981, 10.7326/0003-4819-127-11-199712010-00006
Fracanzani, 1995, Portal hypertension and iron depletion in patients with genetic hemochromatosis, Hepatology, 22, 1127, 10.1002/hep.1840220417
Garcia-Tsao, 2001, Current management of the complications of cirrhosis and portal hypertension: variceal hemorrhage, ascites, and spontaneous bacterial peritonitis, Gastroenterology, 120, 726, 10.1053/gast.2001.22580
de Franchis, 2004, Diagnosis and treatment of portal hypertension, Dig Liver Dis, 36, 787, 10.1016/j.dld.2004.08.001
Boyer, 2003, Transjugular intrahepatic portosystemic shunt: current status, Gastroenterology, 124, 1700, 10.1016/S0016-5085(03)00377-9
Butterworth, 2000, Complications of cirrhosis III. Hepatic encephalopathy, J Hepatol, 32, 171, 10.1016/S0168-8278(00)80424-9
Riordan, 2006, The intestinal flora and bacterial infection in cirrhosis, J Hepatol, 45, 744, 10.1016/j.jhep.2006.08.001
Papatheodoridis, 1999, Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography, Hepatology, 29, 1085, 10.1002/hep.510290437
Arguedas, 2003, Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation, Hepatology, 37, 192, 10.1053/jhep.2003.50023
Fallon, 2005, Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome, J Clin Gastroenterol, 39, S138, 10.1097/01.mcg.0000155570.19340.61
Blendis, 2003, Portopulmonary hypertension: an increasingly important complication of cirrhosis, Gastroenterology, 125, 622, 10.1016/S0016-5085(03)00969-7
Colle, 2003, Diagnosis of portopulmonary hypertension in candidates for liver transplantation: a prospective study, Hepatology, 37, 401, 10.1053/jhep.2003.50060
Gaskari, 2006, Therapy insight: cirrhotic cardiomyopathy, Nat Clin Pract Gastroenterol Hepatol, 3, 329, 10.1038/ncpgasthep0498
Bruix, 2001, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the study of the liver, J Hepatol, 35, 421, 10.1016/S0168-8278(01)00130-1
Sherman, 2004, AASLD single-topic research conference on hepatocellular carcinoma: conference proceedings, Hepatology, 40, 1465, 10.1002/hep.20528
Fattovich, 2004, Hepatocellular carcinoma in cirrhosis: Incidence and risk factors, Gastroenterology, 127, S35, 10.1053/j.gastro.2004.09.014
El-Serag, 2002, Hepatocellular carcinoma and hepatitis C in the United States, Hepatology, 36, S74, 10.1002/hep.1840360710
Roberts, 2004, Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database, Liver Transpl, 10, 886, 10.1002/lt.20137
Fung, 2005, Immunosuppression in liver transplantation: beyond calcineurin inhibitors, Liver Transpl, 11, 267, 10.1002/lt.20373
Perry, 2005, Immunosuppression: towards a logical approach in liver transplantation, Clin Exp Immunol, 139, 2, 10.1111/j.1365-2249.2005.02662.x
Schuppan, 2001, Matrix as a modulator of hepatic fibrogenesis, Semin Liver Dis, 21, 351, 10.1055/s-2001-17556
Benyon, 2001, Extracellular matrix degradation and the role of hepatic stellate cells, Semin Liver Dis, 21, 373, 10.1055/s-2001-17552
Friedman, 2000, Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury, J Biol Chem, 275, 2247, 10.1074/jbc.275.4.2247
Knittel, 1999, Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential, Gastroenterology, 117, 1205, 10.1016/S0016-5085(99)70407-5
Bissell, 2001, Transforming growth factor β and the liver, Hepatology, 34, 859, 10.1053/jhep.2001.28457
Muhlbauer, 2003, A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease, Gastroenterology, 125, 1085, 10.1016/S0016-5085(03)01213-7
Hellier, 2003, Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection, Hepatology, 38, 1468, 10.1053/jhep.2003.09027
Satsangi, 2001, A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis, Gastroenterology, 121, 124, 10.1053/gast.2001.25527
Wright, 2003, Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection, Gut, 52, 1206, 10.1136/gut.52.8.1206
Yoshizawa, 2003, Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease, Tissue Antigens, 61, 159, 10.1034/j.1399-0039.2003.00015.x
Erhardt, 2003, HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis, J Hepatol, 38, 335, 10.1016/S0168-8278(02)00415-4
Silvestri, 2003, CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer, Int J Cancer, 104, 310, 10.1002/ijc.10937
Stickel, 2005, Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis, Arch Intern Med, 165, 1835, 10.1001/archinte.165.16.1835
Huang, 2006, Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C, Gastroenterology, 130, 1679, 10.1053/j.gastro.2006.02.032
Bataller, 2003, Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal, Hepatology, 37, 493, 10.1053/jhep.2003.50127
Issa, 2001, Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors, Gut, 48, 548, 10.1136/gut.48.4.548
Duffield, 2005, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J Clin Invest, 115, 56, 10.1172/JCI200522675
Issa, 2004, Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking, Gastroenterology, 126, 1795, 10.1053/j.gastro.2004.03.009
Poynard, 2003, Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin, Hepatology, 38, 481, 10.1053/jhep.2003.50319
Myers, 2003, Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B, J Hepatol, 39, 222, 10.1016/S0168-8278(03)00171-5
Forns, 2002, Identification of chronic hepatitis C patients without fibrosis by a simple predictive model, Hepatology, 36, 986, 10.1053/jhep.2002.36128
Wai, 2003, A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C, Hepatology, 38, 518, 10.1053/jhep.2003.50346
Berg, 2004, Does noninvasive staging of fibrosis challenge liver biopsy as a gold standard in chronic hepatitis C?, Hepatology, 39, 1456, 10.1002/hep.20226
Le Calvez, 2004, The predictive value of Fibrotest vs APRI for the diagnosis of fibrosis in chronic hepatitis C, Hepatology, 39, 862, 10.1002/hep.20099
Giannini, 2003, Noninvasive diagnosis of fibrosis: the truth is rarely pure and never simple, Hepatology, 38, 1312, 10.1053/jhep.2003.50500
Patel, 2004, Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients, J Hepatol, 41, 935, 10.1016/j.jhep.2004.08.008
Rosenberg, 2004, Serum markers detect the presence of liver fibrosis: a cohort study, Gastroenterology, 127, 1704, 10.1053/j.gastro.2004.08.052
Kelleher, 2005, Prediction of hepatic fibrosis in HIV/HCV co-infected patients using serum fibrosis markers: the SHASTA index, J Hepatol, 43, 78, 10.1016/j.jhep.2005.02.025
Rosenberg, 2003, Rating fibrosis progression in chronic liver diseases, J Hepatol, 38, 357, 10.1016/S0168-8278(03)00010-2
Afdhal, 2004, Evaluation of liver fibrosis: a concise review, Am J Gastroenterol, 99, 1160, 10.1111/j.1572-0241.2004.30110.x
Parkes, 2006, Performance of serum marker panels for liver fibrosis in chronic hepatitis C, J Hepatol, 44, 462, 10.1016/j.jhep.2005.10.019
Pinzani, 2008, Technology insight: non-invasive assessment of hepatic fibrosis by biochemical scores and elastography, Nat Clin Pract Gastroenterol Hepatol, 5, 95, 10.1038/ncpgasthep1025
Castera, 2005, Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C, Gastroenterology, 128, 343, 10.1053/j.gastro.2004.11.018
Colletta, 2005, Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases, Hepatology, 42, 838, 10.1002/hep.20814
Low, 2004, A proteomic analysis of thioacetamide-induced hepatotoxicity and cirrhosis in rat livers, Proteomics, 4, 3960, 10.1002/pmic.200400852
Callewaert, 2004, Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics, Nat Med, 10, 429, 10.1038/nm1006
Asselah, 2005, Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C, Gastroenterology, 129, 2064, 10.1053/j.gastro.2005.09.010
Friedman, 2004, Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications, Nat Clin Pract Gastroenterol Hepatol, 1, 98, 10.1038/ncpgasthep0055
Pinzani, 2005, Fibrosis in chronic liver diseases: diagnosis and management, J Hepatol, 42, S22, 10.1016/j.jhep.2004.12.008
Rockey, 2005, Antifibrotic therapy in chronic liver disease, Clin Gastroenterol Hepatol, 3, 95, 10.1016/S1542-3565(04)00445-8
Fausto, 2004, Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells, Hepatology, 39, 1477, 10.1002/hep.20214
Gupta, 2002, Therapeutic potential of hepatocyte transplantation, Semin Cell Dev Biol, 13, 439, 10.1016/S1084952102001325
Strom, 2003, Hepatocyte transplantation: new possibilities for therapy, Gastroenterology, 124, 568, 10.1053/gast.2003.50072
Kobayashi, 2000, Hepatocyte transplantation in rats with decompensated cirrhosis, Hepatology, 31, 851, 10.1053/he.2000.5636
Ahmad, 2002, Role of intrasplenic hepatocyte transplantation in improving survival and liver regeneration after hepatic resection in cirrhotic rats, Cell Transplant, 11, 399, 10.3727/000000002783985729
Cai, 2002, Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes, Hepatology, 36, 386, 10.1053/jhep.2002.34614
Nagata, 2003, Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation, Gastroenterology, 124, 422, 10.1053/gast.2003.50065
Malhi, 2002, Cell transplantation after oxidative hepatic preconditioning with radiation and ischemia-reperfusion leads to extensive liver repopulation, Proc Natl Acad Sci USA, 99, 13114, 10.1073/pnas.192365499
Benten, 2005, Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat, Hepatology, 42, 1072, 10.1002/hep.20889
Matsuno, 2003, Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis, Gene Ther, 10, 1559, 10.1038/sj.gt.3302052
Malhi, 2002, Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes, J Cell Sci, 115, 2679, 10.1242/jcs.115.13.2679
Nowak, 2005, Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo, Gut, 54, 972, 10.1136/gut.2005.064477
Lagasse, 2000, Purified hematopoietic stem cells can differentiate into hepatocytes in vivo, Nat Med, 6, 1229, 10.1038/81326
Vassilopoulos, 2003, Transplanted bone marrow regenerates liver by cell fusion, Nature, 422, 901, 10.1038/nature01539
Willenbring, 2004, Myelomonocytic cells are sufficient for therapeutic cell fusion in liver, Nat Med, 10, 744, 10.1038/nm1062
Sakaida, 2004, Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice, Hepatology, 40, 1304, 10.1002/hep.20452
Thorgeirsson, 2006, Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence, Hepatology, 43, 2, 10.1002/hep.21015
Rudolph, 2000, Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery, Science, 287, 1253, 10.1126/science.287.5456.1253